RxDoctor Payments DataLook up a doctor →

David Wilt

Nurse Practitioner · Greenville, SCNPI 1083614739

Payments from drug & device makers

$90,374in general payments, 2019–2025

Across 1,523 payments — averaging $59.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$43K
  • Pfizer$18K
  • Amgen$5K
  • Teva Pharmaceuticals USA, Inc.$2K
  • UCB, Inc.$2K
  • Johnson & Johnson$2K
  • plus $18K from 54 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)193$42,568
Pfizer90$18,430
Amgen(2 entities)68$5,224
Teva Pharmaceuticals USA, Inc.100$1,979
UCB, Inc.85$1,952
Johnson & Johnson27$1,681
Biogen68$1,514
EMD Serono, Inc.49$1,115
Neurocrine Biosciences, Inc.71$956
Acadia Pharmaceuticals Inc50$911
AstraZeneca(2 entities)42$860
TG Therapeutics, Inc.31$826
Novartis48$824
Argenx US, Inc.29$772
Eisai Inc.56$761
SK Life Science, Inc.27$620
MDD US Operations, LLC32$591
Sanofi21$545
Axsome Therapeutics, Inc.26$450
Catalyst Pharmaceuticals, Inc.22$393
Bristol Myers Squibb21$393
Otsuka America Pharmaceutical, Inc.19$370
Biohaven Pharmaceutical Holding Company Ltd.25$354
Genentech USA, Inc.17$354
Lilly USA, LLC24$351
Takeda Pharmaceuticals U.S.A., Inc.18$351
Alnylam Pharmaceuticals Inc.20$351
Merz Pharmaceuticals, LLC13$343
Kyowa Kirin, Inc.17$307
Neurelis, Inc.12$268
Octapharma USA, Inc.4$234
Biohaven Pharmaceuticals, Inc.14$217
Avanir Pharmaceuticals, Inc.12$209
Sunovion Pharmaceuticals Inc.15$205
Aquestive Therapeutics, Inc.14$204
ANI Pharmaceuticals, Inc.10$196
Tanabe Pharma America, Inc.9$179
Upsher-smith Laboratories LLC10$167
Grifols USA, LLC6$148
Impel Pharmaceuticals Inc.13$147
Acorda Therapeutics, Inc8$143
Livanova USA, Inc.7$124
Supernus Pharmaceuticals, Inc.7$123
Xeris Pharmaceuticals, Inc.3$121
CSL Behring6$120
Jazz Pharmaceuticals Inc.5$117
Amneal Pharmaceuticals LLC6$115
Scilex Pharmaceuticals Inc.7$107
Sumitomo Pharma America, Inc.3$102
Hospira, Inc.4$96
Cala Health, Inc.1$91
Mallinckrodt Hospital Products Inc.4$80
Hikma Pharmaceuticals USA4$73
Ultragenyx Pharmaceutical Inc.3$69
E.r. Squibb & Sons, L.L.C.2$57
Banner Life Sciences, LLC1$54
Avadel CNS Pharmaceuticals, LLC3$48
Amylyx Pharmaceuticals, Inc.2$47
Impel Pharmaceuticals LLC2$42
Abbott2$38

How this compares

$90,374 in reported general payments places this provider in the 95th percentile of 1,346 nurse practitioner providers in South Carolina.

See all nurse practitioner providers in South Carolina

Medicare billing

Part B allowed, 2024
$498,693
Medicare patients
80
Services billed
15,417

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other nurse practitioner in Greenville

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →